Loss of the aryl hydrocarbon receptor promotes cancer cell resistance to BRAFV600E targeted therapies
Saved in:
| Main Authors: | Mourad Zerfaoui, Dharmeshkumar Patel, Yueqi Zhang, Raymond F. Schinazi, Youssef Errami |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-05-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-025-02235-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BRAFV600E‐PROTAC versus inhibitors in melanoma cells: Deep transcriptomic characterization
by: Solomon O. Alhassan, et al.
Published: (2025-03-01) -
Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis
by: Matteo Puccetti, et al.
Published: (2018-01-01) -
The Aryl Hydrocarbon Receptor Relays Metabolic Signals to Promote Cellular Regeneration
by: Fanny L. Casado
Published: (2016-01-01) -
BRAFV600E and TERT promoter mutations and their impact on recurrent papillary thyroid carcinoma progression
by: Nguyen Thi Nhung, et al.
Published: (2025-07-01) -
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition
by: Valentina Comunanza, et al.
Published: (2016-12-01)